G. Hebenstreit

1.5k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

G. Hebenstreit is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, G. Hebenstreit has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Neurology. Recurrent topics in G. Hebenstreit's work include Treatment of Major Depression (4 papers), Alzheimer's disease research and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). G. Hebenstreit is often cited by papers focused on Treatment of Major Depression (4 papers), Alzheimer's disease research and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). G. Hebenstreit collaborates with scholars based in Germany, Austria and United Kingdom. G. Hebenstreit's co-authors include Peter Riederer, H. Beckmann, Gavin P. Reynolds, E. Sofić, Helmut Heinsen, M.B.H. Youdim, Johannes Kornhuber, Harry Andrews, Christine Konradi and Katrin Fellerer and has published in prestigious journals such as The British Journal of Psychiatry, Neurobiology of Aging and Acta Psychiatrica Scandinavica.

In The Last Decade

G. Hebenstreit

19 papers receiving 1.1k citations

Hit Papers

Increased iron (III) and total iron content in post morte... 1988 2026 2000 2013 1988 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
    1988 591 citations E. Sofić, Peter Riederer et al. Journal of Neural Transmission profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Hebenstreit Germany 9 445 412 397 200 184 20 1.2k
M.B.H. Youdim Israel 18 836 1.9× 448 1.1× 654 1.6× 361 1.8× 246 1.3× 28 1.8k
M.B.H. Youdim Israel 13 676 1.5× 326 0.8× 365 0.9× 266 1.3× 122 0.7× 29 1.3k
P. Jenner United Kingdom 17 956 2.1× 480 1.2× 753 1.9× 254 1.3× 137 0.7× 26 1.8k
M. A. Mena Spain 21 678 1.5× 355 0.9× 563 1.4× 207 1.0× 82 0.4× 46 1.3k
Judes Poirier Canada 25 417 0.9× 601 1.5× 350 0.9× 191 1.0× 153 0.8× 43 1.9k
John M. Candy United Kingdom 18 137 0.3× 374 0.9× 370 0.9× 89 0.4× 233 1.3× 29 890
J. Sian Germany 12 631 1.4× 403 1.0× 419 1.1× 222 1.1× 55 0.3× 17 1.3k
Wei-Yi Ong Singapore 17 110 0.2× 245 0.6× 274 0.7× 115 0.6× 219 1.2× 21 935
Tatyana Verina United States 16 236 0.5× 360 0.9× 499 1.3× 222 1.1× 102 0.6× 23 1.5k
Nobutaka Sakae Japan 23 807 1.8× 517 1.3× 342 0.9× 329 1.6× 122 0.7× 53 1.8k

Countries citing papers authored by G. Hebenstreit

Since Specialization
Citations

This map shows the geographic impact of G. Hebenstreit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Hebenstreit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Hebenstreit more than expected).

Fields of papers citing papers by G. Hebenstreit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Hebenstreit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Hebenstreit. The network helps show where G. Hebenstreit may publish in the future.

Co-authorship network of co-authors of G. Hebenstreit

This figure shows the co-authorship network connecting the top 25 collaborators of G. Hebenstreit. A scholar is included among the top collaborators of G. Hebenstreit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Hebenstreit. G. Hebenstreit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reichmann, Heinz, et al.. (1993). Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. Journal of Neurology. 240(6). 377–380. 42 indexed citations
3.
Hebenstreit, G., et al.. (1992). Treatment of Alzheimer's disease patients with phosphatidylserine. Neurobiology of Aging. 13. S135–S136. 1 indexed citations
4.
Götz, Mario E., Alexius Freyberger, Christoph Hauer, et al.. (1992). Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry. Dementia and Geriatric Cognitive Disorders. 3(4). 213–222. 15 indexed citations
5.
Hebenstreit, G., Gerd Laux, H. Schubert, et al.. (1991). A Double-Blind Comparative Multicentre Study of Controlled-Release Remoxipride, Immediate-Release Remoxipride and Haloperidol in Schizophrenia. Pharmacopsychiatry. 24(5). 153–158. 5 indexed citations
6.
Sofić, E., Lutz Frölich, Peter Riederer, et al.. (1991). Biochemical Membrane Constituents and Activities of Alkaline and Acid Phosphatase and Cathepsin in Cortical and Subcortical Brain Areas in Dementia of the Alzheimer Type. Dementia and Geriatric Cognitive Disorders. 2(1). 39–44. 4 indexed citations
7.
Hebenstreit, G., Ulf Baumhackl, B. Gallhofer, et al.. (1990). Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind Multicenter Study, Austria. PubMed. 32. 177–184. 3 indexed citations
8.
Riederer, Peter, Christine Konradi, G. Hebenstreit, & Moussa B. H. Youdim. (1989). Neurochemical perspectives to the function of monoamine oxidase. Acta Neurologica Scandinavica. 80. 41–45. 53 indexed citations
9.
Hebenstreit, G., Katrin Fellerer, K. Fichte, et al.. (1989). Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine. Pharmacopsychiatry. 22(4). 156–160. 128 indexed citations
10.
Kornhuber, Johannes, Peter Riederer, G. Hebenstreit, et al.. (1989). (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. Journal of Neural Transmission. 77(2-3). 231–236. 197 indexed citations
11.
Baumhackl, Ulf, et al.. (1989). Efficacy and Tolerability of Moclobemide Compared with Imipramine in Depressive Disorder (DSM-III): An Austrian Double-blind, Multicentre Study∗. The British Journal of Psychiatry. 155(S6). 78–83. 80 indexed citations
12.
Hebenstreit, G., et al.. (1989). A pharmacokinetic dose titration study in adult and elderly depressed patients. Acta Psychiatrica Scandinavica. 80(S350). 81–84. 25 indexed citations
13.
Riederer, Peter, E. Sofić, Christine Konradi, et al.. (1989). The Role of Brain Dopamine. 15 indexed citations
14.
Sofić, E., R. Burger, Peter Riederer, et al.. (1989). The reflection of multiple biochemical deficits in nucleus basalis of Meynert of Alzheimer brains to differential scanning thermograms. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 1(1-2). 134–134. 1 indexed citations
15.
Hebenstreit, G., et al.. (1989). [L-tryptophan in pre-delirium and delirium conditions].. PubMed. 16(2). 92–6. 2 indexed citations
16.
Riederer, Peter, et al.. (1989). [Neurochemical perspectives of the function of monoamine oxidases].. PubMed. 16 Suppl 1. 7–10. 2 indexed citations
17.
Sofić, E., Peter Riederer, Helmut Heinsen, et al.. (1988). Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. Journal of Neural Transmission. 74(3). 199–205. 591 indexed citations breakdown →
18.
Hebenstreit, G.. (1982). [Psychopathology of epilepsy according to the WHO-classification (author's transl)].. PubMed. 9(2). 56–8.
19.
Hebenstreit, G.. (1982). [Psychopathology of diurnal and sleep epilepsies (author's transl)].. PubMed. 53(5). 287–90. 1 indexed citations
20.
Hebenstreit, G.. (1981). [Treatment of hypotension caused by psychopharmacological drugs (author's transl)].. PubMed. 131(4). 109–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.B.H. Youdim Breakdown of academic impact, for papers by M.B.H. Youdim Breakdown of academic impact, for papers by P. Jenner Breakdown of academic impact, for papers by M. A. Mena Breakdown of academic impact, for papers by Judes Poirier Breakdown of academic impact, for papers by John M. Candy Breakdown of academic impact, for papers by J. Sian Breakdown of academic impact, for papers by Wei-Yi Ong Breakdown of academic impact, for papers by Tatyana Verina Breakdown of academic impact, for papers by Nobutaka Sakae
Rankless by CCL
2026